FDA Adverse Event Injury Summary report: N

AOSEPT PLUS/CLEAR CARE

MDR report key: 1663343 · Received April 19, 2010

Report

Report Number
8020392-2010-00001
Event Type
Injury
Date Received
April 19, 2010
Date of Event
January 12, 2010
Report Date
February 16, 2010
Manufacturer
CIBA VISION CANADA, INC., STERILE MANUFACTURING (CVSM)
Product Code
LPN
PMA / PMN Number
K050250
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS CASE IS CONSIDERED AS A SIGNIFICANT EPITHELIAL LOSS. A MANUFACTURING INVESTIGATION IS UNDERWAY. IF ANY ABNORMALITY IS FOUND, A F/U REPORT WILL BE PROVIDED. (B) (4).

Description of Event or Problem · 1

AN EYE CARE PRACTITIONER REPORTED THAT A PT EXPERIENCED MODERATE BURNING SENSATION, LEFT EYE, AFTER LENS REMOVAL ASSOCIATED WITH USE OF CLEAR CARE LENS CARE SOLUTION. F/U INFO RECEIVED ON (B) (6) 2010 - EXAMINATION REVEALED SIGNIFICANT CORNEAL STAINING (>50%) AND EDEMA AFTER TWO WEEKS. REFERRED TO OPHTHALMOLOGY FOR FURTHER EVAL. DIAGNOSIS OF LIMBAL STEM CELL DEFICIENCY RELATED TO CHRONIC CONTACT LENS WEAR. TREATMENT CONSISTED OF DOXYCYCLINE 50 MG 1XD, PRESERVATIVE-FREE DEXAMETHASONE DROPS 2XD AND PRESERVATIVE-FREE ARTIFICIAL TEARS. EVENT RESOLVED WITH NO EFFECT ON VISUAL ACUITY. NO LENS WEAR FOR SIX MONTHS. CONSIDERING LASIK EYE SURGERY IN FUTURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AOSEPT PLUS/CLEAR CARE LENS CARE SOLUTION LPN CIBA VISION CANADA, INC., STERILE MANUFACTURING (CVSM) NA 95452

Patients

Seq Age Sex Outcome Treatment
1 38 YR Required Intervention NONE REPORTED